Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML.

JSON

Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, Frøen H, Galteland E, Klungsøyr O, Bergrem A, Vo C, Sørbø H, Eiken B, Lerdal H, Solvang AK, Jensvoll H, Pandzic T, Baliakas P, Dybedal I

Br. J. Haematol. 204 (2) 724-729 [2024-02-00; online 2023-11-28]

PubMed 38016923

DOI 10.1111/bjh.19226

Crossref 10.1111/bjh.19226